Sustained-release composition containing peptides as active ingredient

The present invention relates to a sustained-release drug composition consisting essentially of microparticles of a peptide as the active substance and a biocompatible water-soluble polymer, in particular peptide as meianocortin receptor ligand. The present invention relates also to an injection for...

Full description

Saved in:
Bibliographic Details
Main Authors Mondoly Nathalie, Baronnet Marie-Madeleine, Nourrisson Didier, Harnett Jeremiah, Richard Joël, Laredj Faïza, Hacher Béatrice, Bertocchi Laurent
Format Patent
LanguageEnglish
Published 16.08.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a sustained-release drug composition consisting essentially of microparticles of a peptide as the active substance and a biocompatible water-soluble polymer, in particular peptide as meianocortin receptor ligand. The present invention relates also to an injection formulation comprising the sustained-release drug composition suspended in an injection medium.
Bibliography:Application Number: US201214126365